EA202191103A1 - THERAPEUTIC CONNECTIONS - Google Patents

THERAPEUTIC CONNECTIONS

Info

Publication number
EA202191103A1
EA202191103A1 EA202191103A EA202191103A EA202191103A1 EA 202191103 A1 EA202191103 A1 EA 202191103A1 EA 202191103 A EA202191103 A EA 202191103A EA 202191103 A EA202191103 A EA 202191103A EA 202191103 A1 EA202191103 A1 EA 202191103A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compounds
relates
present
therapeutic
connections
Prior art date
Application number
EA202191103A
Other languages
Russian (ru)
Inventor
Эмма Луиз Блейни
Дункан Джеймс Крик
Саймон Росс Крамплер
Джордж Хайнд
Кэти Луиз Лукас
Барри Филлип Мартин
Ник Чарльз Рэй
Эйлин Мэри Севард
Дэвид Гарет Эванз
Люсилле Ле Бозек
Торстен Новак
Майкл Джеффри Нил Расселл
Сиев Куэн Йеап
Фабьен Жан Гилейн Руссель
Санджеет Сингх Сехми
Original Assignee
Си4Экс ДИСКАВЕРИ ЛИМИТЕД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Си4Экс ДИСКАВЕРИ ЛИМИТЕД filed Critical Си4Экс ДИСКАВЕРИ ЛИМИТЕД
Priority claimed from PCT/GB2019/053012 external-priority patent/WO2020084300A1/en
Publication of EA202191103A1 publication Critical patent/EA202191103A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к соединениям, которые являются активаторами Nrf2. Соединения характеризуются структурной формулой I, определенной в данном документе. Настоящее изобретение также относится к способам получения таких соединений, к фармацевтическим композициям, содержащим их, и к их применению в лечении заболеваний или нарушений, ассоциированных с активацией Nrf2.The present invention relates to compounds that are Nrf2 activators. The compounds are characterized by structural formula I as defined herein. The present invention also relates to methods for the preparation of such compounds, to pharmaceutical compositions containing them, and to their use in the treatment of diseases or disorders associated with Nrf2 activation.

EA202191103A 2019-05-30 2019-10-22 THERAPEUTIC CONNECTIONS EA202191103A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1907674.4A GB201907674D0 (en) 2019-05-30 2019-05-30 Tetrahydroisoquinoline compounds
PCT/GB2019/053012 WO2020084300A1 (en) 2018-10-22 2019-10-22 Therapeutic compounds

Publications (1)

Publication Number Publication Date
EA202191103A1 true EA202191103A1 (en) 2021-09-07

Family

ID=67385738

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191103A EA202191103A1 (en) 2019-05-30 2019-10-22 THERAPEUTIC CONNECTIONS

Country Status (2)

Country Link
EA (1) EA202191103A1 (en)
GB (1) GB201907674D0 (en)

Also Published As

Publication number Publication date
GB201907674D0 (en) 2019-07-17

Similar Documents

Publication Publication Date Title
EA201991399A1 (en) AMINOTRIAZOLOPYRIDINE COMPOUNDS AND THEIR APPLICATION IN TREATMENT OF CANCER
EA201990019A1 (en) COMPOUNDS AND COMPOSITIONS FOR SUSPENSION OF SHP2 ACTIVITY
EA201990665A1 (en) HPK1 REGULATORS BASED ON PYRAZOLOPYRIDINE DERIVATIVES AND THEIR APPLICATION FOR TREATMENT OF CANCER
EA201792047A1 (en) NEW CONNECTIONS
EA202091709A1 (en) DNA PC INHIBITORS
MX2018009257A (en) Benzimidazole derivatives as modulators of ror-gamma.
PH12021550872A1 (en) Therapeutic compounds
EA201790519A1 (en) THERAPEUTIC CONNECTIONS AS INTEGRATORS OF OREXIN-1 RECEPTOR
MX2022005775A (en) Therapeutic compounds and methods of use.
EA201891710A1 (en) THERAPEUTIC CONNECTIONS
EA201992607A1 (en) SOLID FORMS OF UBERODESOXYCHOLATE BERBERIN, THEIR COMPOSITIONS AND METHODS
EA202091020A1 (en) SUBSTITUTED IMIDAZOPYRIDINAMIDES AND THEIR APPLICATION
EA202091708A1 (en) DNA PC INHIBITORS
EA201890449A1 (en) FUMAGILLINUM HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR PRODUCTION AND APPLICATION
EA202290054A1 (en) POLYSPECIFIC ANTIBODIES CONTAINING ONLY HEAVY CHAINS THAT BIND TO CD22 AND CD3
EA202192905A1 (en) COMPOUNDS CONTAINING N-METHYL-2-PYRIDONE AND PHARMACEUTICALLY ACCEPTABLE SALTS
MX2020011405A (en) Benzimidazole derivatives as modulators of retinoid-related orphan receptor gamma (rorï’) and pharmaceutical uses thereof.
EA201792341A1 (en) DERIVATIVES OF PYRAZOLA SUITABLE AS INHIBITOR PROTEINS ACTIVATING 5-LIPOXYGENASE (FLAP)
EA202090448A1 (en) Dihydrooxadiazinones
EA202190588A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
EA202191478A1 (en) HETEROAROMATIC COMPOUNDS AS VANIN INHIBITORS
MX2022014925A (en) Il-17a modulators.
MX2022014924A (en) Il-17a modulators.
EA202191115A1 (en) NEW PYRIDAZINES
MX2022013396A (en) Tetrahydroisoquinoline compounds as nrf2 activators.